Daily FNArena News - Australia

The latest agreement between the government and the pharmacy industry involves cuts to the PBS and a subsequent drag on pharmacy company earnings, with Sigma and API among those impacted.

Suncorp has announced new cost saving initiatives but brokers are wary of how much will translate to the bottom line.

FNArena’s weekly update on short positions in the Australian share market.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.

Brokers accept Technology One is gaining pace in cloud conversions but believe the stock is too expensive.

Brokers look for where the best opportunities lie in the current economic environment where interest rates are likely to remain lower for longer.

James Hardie’s FY15 result was strong, with a special dividend and buy-back announced, but many brokers consider the stock is well priced.

Weekly update on recommendation, target price, and earnings forecast changes.

Cardno has downgraded FY15 guidance on the back of poor conditions in US and Australian markets, which suggests to many brokers dividends could be scaled back or suspended.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.